Effectiveness of pneumococcal vaccination campaigns in humanitarian settings: A modelling study
by Kevin van Zandvoort, Mohamed O. Bobe, Abdirahman I. Hassan, Rachael Cummings, Abdihamid Warsame, Casey L. Pell, Mohamed Ismail Abdi, Saed Ibrahim, Catherine R. McGowan, E. Kim Mulholland, Catherine Satzke, Rosalind M. Eggo, Mohamed Abdi Hergeye, Francesco Checchi, Stefan Flasche Background A large and increasing number of people are forcibly displaced worldwide because of war, food insecurity,…
As wars, food shortages, and other crises force millions of people to flee their homes, a growing health concern arises. Streptococcus pneumoniae, a bacterium, likely contributes significantly to illness in populations affected by turmoil. To combat this issue, pneumococcal conjugate vaccines (PCVs) are commonly utilized in routine immunization programs, such as the Essential Programme on Immunization (EPI), to safeguard against pneumococcal disease.
Typically, these vaccines are given in a three-dose schedule during early infancy or two doses in infancy followed by a booster between 9–18 months of age. However, PCVs are seldom employed in humanitarian responses.
To assess the potential impact of feasible PCV campaigns in such settings, researchers conducted a study in a camp for displaced individuals near Hargeisa, Somaliland. The team first carried out a pneumococcal carriage, malnutrition, and social contact survey to establish parameters for a transmission model that accounts for migration. Subsequently, the researchers projected the effects of mass-vaccination campaigns using either a single or two doses of PCV, with children being the primary focus.
The findings of this modelling study suggest that single-dose mass-vaccination campaigns could prove to be an effective and pragmatic immunization strategy for delivering PCVs to crisis-affected populations, especially when routine EPI services have been disrupted.
Rewritten by urgent.news; may contain errors — check the original.
Source: journals.plos.org